Sign in
Not yet recruitingNo phase

Clinical Features and Treatment of Systemic JIA in Children

Key facts

Who runs it
Sohag University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
50 people, planned
Started
1 Oct 2026
Expected to end
1 Sept 2027
Type of study
Observational
Treatments tested
  • Tocilizumab (Actemra®)
Record updated
11 September 2026

Who can take part

Age
Up to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Children aged <18 years
  • Children diagnosed with systemic juvenile idiopathic arthritis (sJIA) according to the 2019 PRINTO classification criteria
  • Both newly diagnosed and previously diagnosed children with sJIA attending the study center

Who cannot take part

  • Children with other rheumatic or autoimmune diseases
  • Children with infectious, malignant, or other systemic diseases that may mimic sJIA
  • Patients whose medical records have insufficient data for assessment

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to describe the clinical features, disease patterns, and different treatment modalities used in children with systemic juvenile idiopathic arthritis (sJIA). The study will include children younger than 18 years who meet the established classification criteria for sJIA. Clinical findings, laboratory investigations, disease activity, complications, and treatments received will be assessed. Participants will be followed prospectively to evaluate their clinical course and response to different therapeutic approaches. The study will help improve understanding of sJIA in children and provide information about the outcomes associated with different treatment modalities.

Treatments tested

  • Tocilizumab (Actemra®)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Characterization and Different Therapeutic Modalities in Children With Systemic Juvenile Idiopathic Arthritis
Record updated
11 September 2026